Sintilimab combined with Bevacizumab

DRUG2 trials

Sponsors

Sun Yat-sen University, Zhejiang University

Conditions

Advanced Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma

Phase 1

Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma

RecruitingNCT06995105

Zhejiang UniversityAdvanced Hepatocellular Carcinoma (HCC)

Start: 2025-04-09End: 2028-04-01Target: 30Updated: 2025-05-29

Unknown Phase

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

CompletedNCT06199297

Sun Yat-sen UniversityHepatocellular Carcinoma

Start: 2021-03-02End: 2023-07-25Updated: 2024-01-26